help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skinner, M. A.
Right arrow Articles by Freemerman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skinner, M. A.
Right arrow Articles by Freemerman, A.
(American Journal of Pathology. 2005;166:265-274.)
© 2005 American Society for Investigative Pathology

A Human Yeast Artificial Chromosome Containing the Multiple Endocrine Neoplasia Type 2B Ret Mutation Does Not Induce Medullary Thyroid Carcinoma but Does Support the Growth of Kidneys and Partially Rescues Enteric Nervous System Development in Ret-Deficient Mice

Michael A. Skinner*, Somasundaram Kalyanaraman{dagger}, Shawn D. Safford*, Robert O. Heuckeroth{ddagger}, Warren Tourtellotte§, Dominique Goyeau*, Paul Goodfellow{dagger}, Jeffrey D. Milbrandt and Alex Freemerman*

From the Department of Surgery,* Duke University Medical Center, Durham, North Carolina; the Departments of Surgery and Genetics,{dagger} Pediatrics and Molecular Biology and Pharmacology,{ddagger} and Pathology and Immunology, and Medicine, Washington University School of Medicine, St. Louis, Missouri; and the Departments of Pathology and Neurology,§ Northwestern University, Chicago, Illinois

We generated a line of transgenic mice using a yeast artificial chromosome containing the Ret mutation responsible for the multiple endocrine neoplasia type 2B syndrome (MEN 2B). The resulting animals did not develop any of the expected neoplasms associated with MEN 2B. Transgenic animals were then bred with animals lacking murine Ret (RetM) to further evaluate the function of human mutated Ret (RetH2B) in the murine context. Whereas mice lacking RetM exhibit intestinal aganglionosis and the absence of kidneys with other genitourinary anomalies, expression of the RetH2B transgene in RetM-deficient mice allowed significant renal development with a partial rescue of the enteric nervous system. These RetH2B-positive/RetM-deficient mice exhibit normal Ret expression and survive longer than RetM-deficient mice, but still die at 3 to 5 days of age with evidence of enterocolitis. We conclude that the normal expression of a human Ret proto-oncogene with the MEN 2B mutation does not cause any features of MEN 2B in mice. Although the gene is normally expressed in the appropriate target tissues, there is incomplete phenotypic rescue in mice lacking murine Ret. These results suggest important interspecies differences between humans and mice in the function of the Ret oncogene.




This article has been cited by other articles:


Home page
 Genes Dev.Home page
S. Jain, M. Encinas, E. M. Johnson Jr., and J. Milbrandt
Critical and distinct roles for key RET tyrosine docking sites in renal development
Genes & Dev., February 1, 2006; 20(3): 321 - 333.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.